Steve Damon, Micron Biomedical CEO
Vaccine patch startup collects an additional $16M to Series A
Vaccine tech company Micron Biomedical has started 2025 on a positive note, raising over $16 million in a Series A extension round.
The funding will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
